The AI Compliance Matrix: Testing Requirements for Healthcare, Finance, and Government

Sector-by-Sector Breakdown

Healthcare: FDA AI/ML premarket framework + HIPAA data protection + state medical board rules

Finance (Banking/Insurance): SEC AI governance guidance + FedRAMP (if using cloud) + PCI DSS (payments) + SOX (public companies)

Government: FedRAMP for cloud infrastructure + FISMA security controls + OMB AI executive order memoranda + agency-specific policies

Payments: PCI DSS (AI must not bypass card security) + network tokenization rules

Healthcare: The FDA AI/ML Premarket Pathway

What the FDA Wants to See

The FDA's 2021 AI/ML-based Software as a Medical Device guidance laid out the premarket requirements. For moderate-risk devices (most AI), you need:

• Algorithm design and development documentation, What was the training data? How was it split (80/20)? What hyperparameters were tested?
• Performance validation on held-out test data, Sensitivity, specificity, PPV, NPV for diagnostic AI. Clinical endpoint achievement for predictive models.
• Algorithm change protocol, How will you test updates? Continuous learning policies must include drift detection and retraining triggers.
• Labeling and explainability, What are the model's known limitations? When should clinicians override it?
• Real-world performance monitoring, Post-market surveillance: does the model perform as well in clinic as it did in validation?

The Testing Checklist for FDA Compliance

Healthcare AI Testing Checklist
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
□ Cohort composition documented (n, demographics, inclusion/exclusion criteria)
□ Data provenance tracked (source, date range, consent status)
□ Class balance measured (no >30% imbalance without justification)
□ Train/val/test split performed (no data leakage across sets)
□ Performance metrics calculated per FDA guidance:
 □ Sensitivity (true positive rate)
 □ Specificity (true negative rate)
 □ Positive predictive value (precision)
 □ Negative predictive value
 □ Confidence intervals on all metrics
□ Subgroup analysis completed (age, sex, race, comorbidities)
□ Failure mode analysis (what does the model get wrong?)
□ Explainability method chosen and validated
□ Monitoring plan defined (drift triggers, retraining cadence)
□ Clinical impact assessment (how does an error harm the patient?)

HIPAA: The Data Protection Layer

HIPAA compliance for AI means:

• De-identification: Training data must use Safe Harbor (remove 18 direct identifiers) or Expert Determination. Testing datasets may not contain PHI in clear text.
• Access controls: Only authorized researchers access training data. Audit logs required.
• Encryption: Data in transit and at rest must be encrypted (AES-256 standard).
• Business Associate Agreements: If your cloud vendor (AWS, GCP, Azure) processes PHI, signed BAAs are non-negotiable.

Real-world catch: Many teams pass FDA validation but fail HIPAA post-market audits because their monitoring dashboards displayed patient identifiers or their model audit logs weren't properly segregated. Treat monitoring systems as PHI-adjacent.

Finance: The Regulatory Trifecta (SEC, FedRAMP, SOX)

SEC AI Governance Guidance (2023)

The SEC doesn't approve or reject AI outright. Instead, they require financial firms to document:

• Model governance: Who owns the model? Who monitors it? Who has authority to take it offline?
• Validation and testing: Independent model validation (separate from the development team). Backtesting results on historical data.
• Conflicts of interest: If your AI makes trading decisions, the SEC wants to know about potential conflicts (does it favor your own positions?). Disclosure required.
• Cybersecurity and data quality: How do you handle data breaches? Poisoned training data?
• Disclosures: Public companies must disclose material AI risks in 10-Ks and proxy statements.

FedRAMP: Infrastructure Security for Cloud AI

If your financial AI runs on AWS, GCP, or Azure, you may need FedRAMP Moderate or High authorization. FedRAMP requires:

• 800-53 security controls (134+ controls covering access, encryption, logging, incident response)
• Continuous monitoring (monthly scans, annual assessments)
• Third-party assessment organization (3PAO) validation
• System security plan documenting every control implementation

For AI specifically, FedRAMP auditors will ask: Can you prove your model hasn't been poisoned? Do you have data lineage for all training inputs? Can you demonstrate that model updates went through security review?

SOX: For Public Companies

If your firm is publicly traded, Sarbanes-Oxley Section 404 requires auditors to attest that internal controls over financial reporting are effective. AI used in finance (pricing, risk models, fraud detection) falls under this umbrella. Auditors will demand:

• Model change documentation (what changed, why, who approved it?)
• Validation results before production deployment
• Monitoring dashboards showing model performance post-launch
• Incident logs (when the model failed, what was the impact, how was it remediated?)

PCI DSS: For Payment Systems

If your AI touches payment data, PCI DSS v4.0 applies. Key testing requirements:

• AI must not learn card numbers, CVVs, or PINs (no cardholder data in training sets)
• Tokenized data only for fraud detection training
• Annual penetration testing of model inference endpoints
• Network segmentation: AI service must be in isolated segment with restricted data access

Finance Testing Checklist

Finance AI Testing Checklist
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
SEC Governance:
□ Model ownership and accountability matrix defined
□ Independent validation team assigned (separate from dev team)
□ Conflict of interest assessment completed and filed
□ Backtesting results calculated (historical performance on prior X years)
□ Model documentation reviewed by compliance (not just data science)

FedRAMP (if cloud-based):
□ System Security Plan completed with all 134+ controls mapped
□ Infrastructure encryption verified (data at rest, in transit)
□ Access logs reviewed (who accessed model, when, from where?)
□ Continuous monitoring (monthly vulnerability scans)
□ 3PAO assessment scheduled

SOX (if public):
□ Model change control process documented
□ Segregation of duties verified (dev ≠ deployer ≠ auditor)
□ Version control logs auditable (no unsigned commits)
□ Monitoring dashboard KPIs agreed with auditors
□ Incident response playbook tested

PCI DSS (if payments):
□ No cardholder data in training, test, or validation sets
□ Tokenization verified for all payment-related inputs
□ Model inference endpoint penetration tested
□ Network segmentation diagram provided to assessor

Government: FedRAMP, FISMA, and Executive Order

Government AI is the most complex. A federal agency deploying AI must navigate:

• FedRAMP: Same 134 controls as finance, but government auditors are stricter.
• FISMA: Security categorization (Low/Moderate/High) based on impact analysis. Most AI is Moderate or High.
• OMB AI Executive Order (2023): Agencies must conduct impact assessments, ensure human review for high-risk decisions, and maintain audit trails.
• Agency-specific requirements: HHS, DoD, and VA have additional AI governance policies.

Testing for Government AI

Beyond the standard FedRAMP checklist:

• Bias and fairness audits: Is your AI equally accurate across demographic groups? Executive Order 14110 requires testing.
• Transparency and explainability: Can a government employee explain the model's decision to a citizen? If not, restructure it.
• Continuous monitoring with drift detection: Government performance requirements are strict. If accuracy drops >5%, automatic retraining must trigger.
• Rollback capability: Can you disable the AI in 24 hours if something goes wrong?

Building the Integrated Compliance Testing System

The pattern across all four sectors is clear: compliance testing requires three layers.

Most teams test these in isolation. Mature teams automate them together:

• Automated performance monitoring feeds into governance dashboards (if accuracy drops, ticket auto-created for model review)
• Governance change logs trigger infrastructure scans (model updated → security team runs pentests)
• Infrastructure changes require performance re-validation (security patch → re-run model validation suite)

This integration is where alt.qa shines. A unified testing system can run FDA validation suites, FedRAMP scans, SOX audit reports, and fairness audits in a single orchestrated workflow. The alternative is spreadsheet hell.

Common Pitfalls and How to Avoid Them

• Testing only performance, ignoring governance: Your model is 99% accurate but has no change control? Regulators will reject it. Test the process, not just the algorithm.
• Assuming one checklist covers everything: FDA, SEC, and FedRAMP have overlapping requirements, but they're not identical. Create a compliance matrix mapping requirements to test cases.
• Post-market monitoring as afterthought: Most compliance failures happen post-deployment when model performance drifts. Build monitoring from day one.
• Treating AI as a black box: Regulators demand explainability. Use interpretable models (XGBoost, linear models) or add SHAP/LIME explanations to black boxes.
• Forgetting the human loop: All regulated AI should have a "clinician override, " "trader review, " or "analyst sign-off" step. Test that the human-AI workflow works in practice.

The Practical Starting Point

If you're overwhelmed, start here:

1. Identify your regulatory landscape (which frameworks apply to you?).
2. Create a compliance matrix (map each requirement to a test case).
3. Instrument your model with logging (capture inputs, outputs, decisions, drift metrics).
4. Build automated test suites for each framework (FDA validation, FedRAMP scans, fairness audits).
5. Integrate with your deployment pipeline (no code goes live without passing all compliance checks).

Compliance is a floor, not a ceiling. But it's a necessary floor. Get it right, and you'll move faster than competitors still stuck in manual audit purgatory.